COVID-19 Update | April 10, 2020

COVID-19 News

COVID-19 Update | April 10, 2020

April 10, 2020

As circumstances around coronavirus (COVID-19) continue to evolve quickly, the California Biotechnology Foundation wants to keep you informed about the progress being made by biotechnology researchers in California and across the nation to expand available testing, treat the virus and prevent its spread.

The following resources track what progress has been made as of April 10, 2020. Notable advancements include:



Recent News:

  • Pfizer Identifies Lead Coronavirus Drug Candidate
    Wall Street Journal – April 9, 2020
    Pfizer Inc.  has found a promising but early potential coronavirus treatment, which the drugmaker aims to begin testing in patients this summer. Laboratory research suggests the drug candidate blocks the new coronavirus from replicating.
  • Arcturus Therapeutics Announces Clinical Trial Timeline for its COVID-19 Vaccine
    Biospace – April 9, 2020
    Arcturus Therapeutics announced plans to initiate a human clinical trial this Summer for its COVID-19 vaccine, also known as LUNAR-COV19. The trial plans to enroll up to 76 healthy volunteer adults including elderly individuals, with follow-up over several months to evaluate extent and duration of immune response.
  • COVID-19 Vaccine Progress from 8 BioHealth Capital Region Companies
    Bio Buzz – April 7, 2020
    In addition to the region’s medical diagnostics companies working to bolster testing capabilities, BHCR companies like Altimmune, Novavax, Emergent Biosolutions, Sanaria, GlaxoSmithKline, Cel-sci and Integrated Biotherapeutics are racing to develop a COVID-19 vaccine.
  • Inovio Pharmaceuticals begins human trials for COVID-19 vaccine
    San Diego Union-Tribune – April 6, 2020
    Inovio Pharmaceuticals, which developed a potential vaccine for COVID-19 at its San Diego lab, has begun an early Phase 1 human trial for the drug involving 40 healthy adult volunteers in two states. The first wave of volunteers received doses on Monday.
  • Uniting Life Sciences to Tackle COVID-19 From All Angles
    Biocom – April 6, 2020
    Several therapeutics are now in clinical trials and more than 20 vaccines are in development with many members within our California life science community leading the charge. Check out all that Biocom’s members are working on related to COVID-19 at our coronavirus resource center.
  • Researchers harness new technology for rapid COVID-19 vaccine development
    Fierce Biotech – April 6, 2020
    Scientists working for a spinoff of Massachusetts General Hospital called Voltron Therapeutics started looking for partners to help develop a vaccine as quickly as possible. They formed a joint venture with Hoth Therapeutics, named HaloVax, and tasked it with using a vaccine technology developed at MGH to find a COVID-19 candidate.


Rely on California Biotechnology Foundation to monitor breaking news and provide updates on the latest advancements in COVID-19 diagnostics, vaccines and treatments.


Stay informed on the latest news and trends on the economic and health benefits of this industry by visiting the new


If you have any questions about informational briefings contact California Biotechnology Foundation Executive Director Patty Cooper at (916)764-2434 or [email protected].